Search | MSF Access

3098 results found
There are 0 active filters

3098 results found

Technical brief |

09 February 2026

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

MSF recommendations on WHO Pathogen Access and Benefit-Sharing (PABS) systems

Tags Pandemic preparedness

Statement |

06 February 2026

Report on the implementation of the framework of engagement with non-state actors – EB158/42

MSF Statement: EB158/42

Tags WHO Executive Board

Events |

06 February 2026

MSF statements at WHO Executive Board 158th session

MSF representatives spoke at the 158th session of the WHO Executive Board (EB) on a number of topics related to access to medical tools and public health.

Tags DiabetesAntimicrobial resistanceVaccines WHO Executive Board

Statement |

05 February 2026

Draft global plan of action for the health of Indigenous Peoples – EB158/29

MSF Statement: EB158/29

Tags WHO Executive Board

Statement |

04 February 2026

WHO’s work in health emergencies – EB158/20

MSF Statement: EB158/20

Tags WHO Executive Board

Statement |

04 February 2026

Draft updated global action plan on antimicrobial resistance – EB158/18

MSF Statement: EB158/18

Tags Antimicrobial resistance WHO Executive Board

Statement |

04 February 2026

Strengthening the evidence base for public health and social measures – EB158/21

MSF Statement: EB158/21

Tags WHO Executive Board

Statement |

04 February 2026

Implementation of resolution WHA75.11 (2022) – EB158/24

MSF Statement: EB158/24

Tags WHO Executive Board

Statement |

03 February 2026

Immunization Agenda 2030: Mid-term review – EB158/8

MSF Statement: EB158/8

Tags Vaccines WHO Executive Board

Statement |

03 February 2026

Mental health: Implementation of related resolutions and decisions – EB158/7  

MSF Statement: EB158/7

Tags WHO Executive Board

Statement |

02 February 2026

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of noncommunicable diseases – EB158/6

MSF Statement: EB158/6

Tags WHO Executive Board

Majida, 58, a Syrian patient at MSF’s non-communicable diseases (NCDs) project in Irbid governorate, northern Jordan, close to the Syrian borders, has her blood pressure ochecked by an MSF nurse in one of the two NCDs clinics in Irbid

Statement |

16 December 2025

Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions

With 75% of deaths related to NCDs and mental health conditions in low- and middle-income countries – accounting for 32 million lives lost each year – affordable access to key medical tools should be a necessity, not a luxury

Tags Cardiovascular diseasesDiabetes Diabetes

Newsletter |

06 December 2025

Algorithms for good!

In this issue:

Video: We rallied with John Green for children with tuberculosis
MSF’s Test, Avoid, Cure Tuberculosis in Children project released promising data from an operational research study regarding algorithm use
Video: Watch as experts discuss antimicrobial resistance in conflict-affected settings
And more on: vaccines, intellectual property, and insulin pens

Insulin pens, provided by MSF to diabetes type I patients below 15 years old.

Press release |

02 December 2025

MSF responds to Novo Nordisk’s discontinuation of key insulin products in EU/EEA

Discontinuation of key insulin products for commercial reasons another example of pharmaceutical corporations putting profits before people’s health.

Tags Diabetes Diabetes Insulin

02 December 2025

CSO Open Letter to European Parliament’s Committee on Public Health

CSOs write to European Parliament’s Committee on Public Health

Statement |

01 December 2025

MSF Statement at IGWG4

MSF Statement at the WHO Pandemic Agreement discussions

Tags Pandemic preparedness World Health Organization

Every 3 minutes, a child dies of tuberculosis

Did you know that every 3 minutes, a child dies of tuberculosis? That’s not just concerning, that’s a failure.

Rebecca and her son Ajou, who has type 1 diabetes and frequently goes into diabetic ketoacidosis, often requiring intensive care unit admission during hospital visits. South Sudan, 2025.

Feature story |

27 November 2025

How insulin pens are changing lives in South Sudan’s remote villages

Insulin pens and glucose monitors would be life changing for children across South Sudan, but they remain out of reach for most.

Tags Diabetes Diabetes Insulin South Sudan

Video |

20 November 2025

Discussion: Antimicrobial resistance in conflict-affected settings

Antimicrobial resistance in conflict-affected settings: A discussion on field realities, operational challenges & policy recommendation

Tags Antimicrobial resistance

19 November 2025

MSF urges reform of United States-Mexico-Canada Agreement's (USMCA) pharmaceutical intellectual property provisions to safeguard public health

MSF urges reform of United States-Mexico-Canada Agreement (USMCA) pharmaceutical intellectual property provisions to safeguard public health

Tags Intellectual property and trade CanadaUnited States of America

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

Report on the implementation of the framework of engagement with non-state actors – EB158/42

MSF statements at WHO Executive Board 158th session

Draft global plan of action for the health of Indigenous Peoples – EB158/29

WHO’s work in health emergencies – EB158/20

Draft updated global action plan on antimicrobial resistance – EB158/18

Strengthening the evidence base for public health and social measures – EB158/21

Implementation of resolution WHA75.11 (2022) – EB158/24

Immunization Agenda 2030: Mid-term review – EB158/8

Mental health: Implementation of related resolutions and decisions – EB158/7

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of noncommunicable diseases – EB158/6

Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions

Algorithms for good!

MSF responds to Novo Nordisk’s discontinuation of key insulin products in EU/EEA

CSO Open Letter to European Parliament’s Committee on Public Health

MSF Statement at IGWG4

Every 3 minutes, a child dies of tuberculosis

How insulin pens are changing lives in South Sudan’s remote villages

Discussion: Antimicrobial resistance in conflict-affected settings

MSF urges reform of United States-Mexico-Canada Agreement's (USMCA) pharmaceutical intellectual property provisions to safeguard public health